Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Calcitonin -- 1998].

R S Lorenc1

  • 1Zakładu Biochemii i Medycyny Doświadczalnej Instytutu Pomnik-Centrum Zdrowia Dziecka.

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|April 2, 1999
PubMed
Summary

Calcitonin regulates calcium levels and is used for osteoporosis and pain relief. Research is exploring its effectiveness in preventing fractures, with intranasal preparations showing promise.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group.

Archives of osteoporosis·2022
Same author

Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).

Current medical research and opinion·2012
Same author

Idiopathic juvenile osteoporosis--an analysis of the muscle-bone relationship.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2006
Same author

Efficacy and safety of ibandronate given by intravenous injection once every 3 months.

Bone·2004
Same author

[Progress in measurement of the calcaneus using ultrasonic methods in children and adolescents].

Przeglad lekarski·2000
Same author

[Osteoporosis in children].

Przeglad lekarski·2000

Area of Science:

  • Endocrinology and Bone Metabolism
  • Pharmacology

Context:

  • Calcitonin is a key hormone regulating systemic calcium homeostasis.
  • Its structure, synthesis, and clinical applications have been developed since its 1961 discovery.
  • Current uses include hypercalcemia, Paget's disease, algodystrophy, osteoporosis, and pain management.

Purpose:

  • To review the established and emerging therapeutic applications of calcitonin.
  • To highlight ongoing research into calcitonin's antifracture efficacy in osteoporosis.
  • To note advancements in calcitonin delivery, such as intranasal preparations.

Summary:

  • Calcitonin, a vital hormone for calcium regulation, has a well-established clinical profile.
  • Therapeutic applications span metabolic bone diseases, hypercalcemia, and pain relief.
  • Current research focuses on its potential to prevent fractures in osteoporosis, with intranasal formulations representing a significant development.

Impact:

  • Provides a comprehensive overview of calcitonin's role in calcium homeostasis and clinical practice.
  • Underscores the evolving understanding of calcitonin's therapeutic benefits, particularly in osteoporosis.
  • Informs clinicians and researchers about the potential of calcitonin, including novel delivery methods.

Related Experiment Videos